Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

ALS is a disease of continual losses and trade-offs. We walk a tightrope between safety and independence, and caution and quality of life.

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Columnist Dagmar Munn turns to affirmations and positive self-talk on those occasional days when she feels shut down.

The genes included those involved in the function of energy-producing mitochondria, lipid and iron metabolism, and the ...

New York was the only state to receive the highest mark on the ALS Association’s latest report cards, the association said.

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...